New tracers developed in positron emission tomography: A possible second breath in targeting tumour hypoxia?

被引:5
作者
Baillet, G. [1 ]
Groheux, D. [1 ]
Barre, E. [1 ]
Toubert, M. -E. [1 ]
Dechaud, C. [1 ]
Teyton, P. [1 ]
de Hemricourt, E. Le Beau [2 ]
Moretti, J. -L. [1 ]
机构
[1] Hop St Louis, Nucl Med Serv, F-75475 Paris 10, France
[2] Ctr Imagerie Nucl Dunkerque, F-59240 Dunkerque, France
来源
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE | 2008年 / 32卷 / 12期
关键词
PET imaging; Hypoxia; FAZA; Cu-ATSM;
D O I
10.1016/j.mednuc.2008.07.009
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
There is an increasing interest for targeting of tumor hypoxia and our paper aimed to emphasize the main points of this topic. We review new insights at cellular level and focus on the leading part of hypoxia inducible factor one alpha and its connections with angiogenesis. We shortly describe different methods to assess tissue hypoxia then zoom on to positron emission tomography and its acknowledged tracers F-18-fluoromisonidazole and F-18-fluoroerythronitroimidazole. Recent studies concerning two new promising tracers Cu(II)-diacetyl-bis(N(4)-methylthiosemicarbazone) and FAZA are reviewed, and the respective value of the tracers is discussed. (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:607 / 613
页数:7
相关论文
共 54 条
[1]   Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine [J].
Beck, Roswitha ;
Roeper, Barbara ;
Carlsen, Janette Maria ;
Huisman, Marc Cornelis ;
Lebschi, Julia Aloisia ;
Andratschke, Nicolaus ;
Picchio, Maria ;
Souvatzoglou, Michael ;
Machulla, Hans-Juergen ;
Piert, Morand .
JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (06) :973-980
[2]   A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy [J].
Chao, KSC ;
Bosch, WR ;
Mutic, S ;
Lewis, JS ;
Dehdashti, F ;
Mintun, MA ;
Dempsey, JF ;
Perez, CA ;
Purdy, JA ;
Welch, MJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (04) :1171-1182
[3]  
Cher LM, 2006, J NUCL MED, V47, P410
[4]  
Cherk MH, 2006, J NUCL MED, V47, P1921
[5]   Determination of tumour hypoxia with the PET tracer [18F]EF3:: improvement of the tumour-to-background ratio in a mouse tumour model [J].
Christian, Nicolas ;
Bol, Anne ;
De Bast, Marc ;
Labar, Daniel ;
Lee, John ;
Mahy, Pierre ;
Gregoire, Vincent .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (09) :1348-1354
[6]   Molecular origins of cancer: Oncogenes and cancer [J].
Croce, Carlo M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (05) :502-511
[7]   In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM [J].
Dehdashti, F ;
Mintun, MA ;
Lewis, JS ;
Bradley, J ;
Govindan, R ;
Laforest, R ;
Welch, MJ ;
Siegel, BA .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (06) :844-+
[8]   Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM:: Relationship to therapeutic response -: A preliminary report [J].
Dehdashti, F ;
Grigsby, PW ;
Mintun, MA ;
Lewis, JS ;
Siegel, BA ;
Welch, MJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (05) :1233-1238
[9]   Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone) [J].
Dehdashti, Farrokh ;
Grigsby, Perry W. ;
Lewis, Jason S. ;
Laforest, Richard ;
Siegel, Barry A. ;
Welch, Michael J. .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (02) :201-205
[10]   Energy deregulation: Licensing tumors to grow [J].
Garber, K .
SCIENCE, 2006, 312 (5777) :1158-1159